J7301 – Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg

Long description

Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg

Short description

Skyla, 13.5 mg

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

S Non-covered by Medicare statute

BETOS category

P6C Minor procedures - other (Medicare fee schedule)

Added

January 1, 2014

Last change

January 1, 2017 – No change

Nearby J codes

• J7214 – Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
• J7294 – Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
• J7295 – Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
• J7296 – Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
• J7297 – Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
• J7298 – Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
• J7299 – Intrauterine copper contraceptive (miudella)
• J7300 – Intrauterine copper contraceptive (paragard)
• J7302 – Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
• J7303 – Contraceptive supply, hormone containing vaginal ring, each
• J7304 – Contraceptive supply, hormone containing patch, each
• J7306 – Levonorgestrel (contraceptive) implant system, including implants and supplies
• J7307 – Etonogestrel (contraceptive) implant system, including implant and supplies
• J7308 – Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
• J7309 – Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
• J7310 – Ganciclovir, 4.5 mg, long-acting implant